解释比利时轮状病毒疫苗对轮状病毒住院影响形成平台期的原因
该分析基于比利时11家医院2005年起≤5岁儿童轮状病毒住院数据(RotaBIS研究),用数学模型模拟不同年龄组住院情况并与观察数据拟合。结果显示观察数据住院下降较「理想」模拟更慢,三年后在高残留住院率趋于平稳;较高残留住院率可由疫苗项目11月启动接近轮状病毒季节性高峰解释。作者认为希望最大化疫苗影响的国家应远在轮状病毒季节性高峰前启动接种。
要点
- 观察数据住院下降较「理想」模拟更慢,三年后在高残留住院率趋于平稳。
- 较高残留住院率可由疫苗项目11月启动接近轮状病毒季节性高峰解释。
- 作者认为若想最大化影响,应远在轮状病毒季节性高峰前启动接种。
核心结论
- 结果显示,希望最大化轮状病毒疫苗影响的国家应远在轮状病毒季节性高峰前启动接种。
- 二次感染来源比疫苗效力衰减更能解释比利时观察到的数据。
研究设计与样本
- 分析基于自2005年起11家医院≤5岁儿童轮状病毒病住院数据(RotaBIS研究),普遍轮状病毒疫苗接种运动于2006年末启动。
- 采用数学模型模拟不同年龄组轮状病毒住院,使用疫苗效力和群体效应,受疫苗覆盖率、疫苗效力衰减和二次感染来源影响。
- 模型采用优化分析将模拟曲线拟合至观察数据,应用Solver加载项软件。
- 模型模拟「理想」疫苗引入(最大覆盖率、最大群体效应、无衰减)以最大化住院减少,并与最佳拟合模拟曲线比较。
- 通过修改模型输入值识别对住院影响最大的因素。
主要发现
- 与「理想」模拟相比,观察数据显示住院下降更慢,并在三年后以更高的残留住院率趋于平稳。
- 初始下降较慢由未接种儿童的群体效应解释。
- 较高残留住院率由疫苗项目11月启动接近轮状病毒季节性高峰解释,这导致首个轮状病毒病高峰季累积疫苗覆盖率低,随之出现二次感染来源,进而降低群体效应,导致净影响减弱。
临床怎么用
- 作者认为,希望最大化轮状病毒疫苗影响的国家应远在轮状病毒季节性高峰前启动接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Observational data on the reduction in hospitalisations after rotavirus vaccine introduction in Belgium suggest that vaccine impact plateaued at an unexpectedly high residual hospitalisation rate. The objective of this analysis was to identify factors that influence real-world vaccine impact. METHODS: Data were collected on hospitalisations in children aged ≤ 5 years with rotavirus disease from 11 hospitals since 2005 (the RotaBIS study). The universal rotavirus vaccination campaign started late in 2006. A mathematical model simulated rotavirus hospitalisations in different age groups using vaccine efficacy and herd effect, influenced by vaccine coverage, vaccine waning, and secondary infection sources. The model used optimisation analysis to fit the simulated curve to the observed data, applying Solver add-in software. It also simulated an 'ideal' vaccine introduction maximising hospitalisation reduction (maximum coverage, maximum herd effect, no waning), and compared this with the best-fit simulated curve. Modifying model input values identified factors with the largest impact on hospitalisations. RESULTS: Compared with the 'ideal' simulation, observed data showed a slower decline in hospitalisations and levelled off after three years at a higher residual hospitalisation rate. The slower initial decline was explained by the herd effect in unvaccinated children. The higher residual hospitalisation rate was explained by starting the vaccine programme in November, near the rotavirus seasonal peak. This resulted in low accumulated vaccine coverage during the first rotavirus disease peak season, with the consequential appearance of secondary infection sources. This in turn reduced the herd effect, resulting in a diminished net impact. CONCLUSIONS: Our results indicate that countries wishing to maximise the impact of rotavirus vaccination should start vaccinating well ahead of the rotavirus seasonal disease peak. This maximises herd effect during the first year leading to rapid and high reduction in hospitalisations. Secondary infection sources explain the observed data in Belgium better than vaccine waning.
引用
- Standaert B, Strens D, Raes M, et al. Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium. Vaccine. 2022. PMID: 35190208. doi:10.1016/j.vaccine.2022.02.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。